Consolidated Statements of Cash Flows - USD ($)		12 Months Ended
		Dec. 31, 2020		Dec. 31, 2019
Cash flows from operating activities:
Net loss		$ (4,250,861)		$ (8,074,448)
Adjustments to reconcile net loss to net cash provided by operating activities
Depreciation and amortization		472,337		1,149,896
Amortization of deferred gain on sale/leaseback		45,700		78,477
Amortization of ROU Asset		649,615		1,129,878
Gain on forgiveness of PPP Funding		(1,047,700)
Provision for losses on accounts receivable		(11,110)		304,180
Provision for losses on inventories				1,247,581
Impairment on assets held for sale				604,483
Gain on deconsolidation of Clever				(218,534)
Impairment of Note Receivable		1,276,813
Impairment of prepaid, current & non current assets				168,931
Impairment of long-lived assets				1,686,929
Stock based compensation				177,850
Income Tax Receivable		(403,074)
Deferred income taxes				135,094
Loss on disposition of asset				17,480
Change in assets and liabilities:
Accounts receivable		4,157,800		475,061
Inventories		2,730,049		4,507,221
Prepaid expenses and other assets		(268,207)		28,232
Trade payables		(1,302,201)		1,177,003
Change in ROU Liability		(649,615)		(1,129,878)
Accrued liabilities		352,883		201,417
Net cash provided by operating activities		1,752,429		3,666,853
Cash flows from investing activities:
Purchases of property, plant and equipment		(202,203)		(80,472)
Net cash used in investing activities		(202,203)		(80,472)
Cash flows from financing activities:
Change in checks written in excess of bank balance				(636,142)
Repayment of debt and revolving line of credit		(10,995,083)		(3,454,494)
Proceeds from advance from investor		1,500,000
Proceeds from issuance of common stock		333,334
Cash paid for stock issuance costs		(1,024,313)
Cash paid for deferred financing fees		(83,424)		(146,102)
Proceeds from PPP		1,047,700
Proceeds from issuance of long-term debt		1,243,684		650,000
Net cash used in financing activities		(1,384,835)		(3,586,738)
Effect of exchange rate changes on cash		(389,842)		421,611
Net decrease in cash and cash equivalents		(224,451)		421,254
Cash and cash equivalents at beginning of year		849,404	[1]	428,150
Cash and cash equivalents at end of year	[1]	624,953		849,404
Supplemental disclosure of cash flow information:
Cash payments for interest		1,269,000		2,097,682
Common stock issued		306,000
Accrued dividend and accretion on preferred stock		412,000
Issuance of Placement agent warrants in connection with Series A Preferred offering		919,000
Amortization of beneficial conversion feature and deemed dividend on Series A and Series B Preferred stock		3,968,000
Conversion from Accounts Payable To Common Stock [Member]
Supplemental disclosure of cash flow information:
Common stock issued				303,000
Conversion of Accounts Payable to Convertible Preferred Stock [Member]
Supplemental disclosure of cash flow information:
Conversion of accounts payable debt to Series A Preferred		478,000
Conversion from Notes Payable To Common Stock [Member]
Supplemental disclosure of cash flow information:
Common stock issued				600,000
Series A Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of preferred stock		5,093,267
Series B Preferred Stock [Member]
Cash flows from financing activities:
Proceeds from issuance of preferred stock		$ 1,500,000

[1] The cash flows related to discontinued operations of $195,496 and $4,307 as of December 31, 2020 and 2019, respectively, have not been segregated, and are included in the Consolidated Statements of Cash Flows. The cash and equivalents amounts presented above differ from cash and equivalents in the Consolidated Balance Sheets due to cash included in "Current assets of discontinued operations."